Tomorrow we publish an exclusive interview with @uspto director Michelle Lee. She talks reform, pharma IPR carve-outs, Google and much more.
As predicted, IAM is considered to be in the pocket of the EPO because we do not see things like @schestowitz. https://t.co/c2zHkSI2E1
Excellent @nytimes piece on Bass/@SpangenBlog pharma IPR challenges. Bottom line - patents are valid or they're not. https://t.co/7e8JZiibYq
Samsung’s $23 million Netlist deal shows Fortress IP financing model is about much more than stick licensing
South Korea’s Samsung Electronics and US cloud computing and data storage company Netlist have entered into a licensing agreement that will see the two collaborate on the development of NVDIMM-P non-volatile memory solutions. The deal shows that high-value licensing deals can still happen away from IP infringement disputes; and that assertion is far from being the only way...
Ericsson locks down a global patent licence agreement with iBall thanks to Delhi High Court injunction
Ericsson’s campaign to sign up licensees among smartphone sellers in India has been one of the country’s biggest patent stories over the last two years, and its battles in the High Court of Delhi have produced some of the region’s most interesting rulings on standards essential patents (SEPs) and fair, reasonable and non-discriminatory (FRAND) terms during that time. It has...
The sales and technology transactions portal, IAM Market, launched on 20th October. It promises to change the way sales, licensing and transfers of IP are conducted in the future. To demonstrate this, we have put together an infographic that highlights the innovations and benefits of IAM Market. So far, hundreds of users have registered for free to browse the IP and technology currently on...
Antitrust compliance has become one of the most important aspects of conducting IP business in Asia. IAM shines a light on the region’s key competition watchdogs, their new patent policies and what these mean for rights holders
IAM Patent 1000
The definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions, with a special section on expert witnesses in the United States.Visit site